UK 356618

Skip to product information
1 of 1

Selleck Chemicals

SKU:E7519

Regular price €0,00 EUR
Regular price Sale price €0,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

UK 356618 is an inhibitor of MMP used in studies of protease biology. It is especially relevant in cancer, immunology, and inflammation models, where defined compound exposure can be linked to proteolytic processing and cleavage-dependent signaling.

By inhibiting MMP, UK 356618 can be used to examine proteolytic processing and cleavage-dependent signaling. This target class is commonly examined through protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping. In cancer, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving MMP
  • Concentration-response inhibition and target-dependence studies
  • Protease-activity, cleavage, and substrate-processing assays
  • Phenotypic profiling in cancer, immunology, and inflammation models

Overall, UK 356618 is appropriate when a defined chemical perturbant is needed to connect MMP with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
MMP
Target Class:
Protease
Research Area:
Cancer • Immunology • Inflammation
CAS No.:
230961-08-7
Molecular Weight:
557.72
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.